✦ LIBER ✦

Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells

✍ Scribed by Chi Zhang, Xuening Duan, Ling Xu, Jingming Ye, Jianxin Zhao, Yinhua Liu

Book ID: 118796803
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 623 KB
Volume: 136
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-2316-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormone-receptor expression and activity

Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients

✍ Filippo Montemurro; Valentina Rossi; Maria Cossu Rocca; Rossella Martinello; Ele 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

EGFR over-expression and activation in h

EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance

✍ Rajiv Dua; Jianhuan Zhang; Phets Nhonthachit; Elicia Penuel; Chris Petropoulos; 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 627 KB

Immunohistochemical expression of HER1,

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

✍ Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Akihiro Hirakawa; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

Trastuzumab in combination with metronom

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

✍ Laura Orlando; Anna Cardillo; Raffaella Ghisini; Andrea Rocca; Alessandra Balduz 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 252 KB

In vitro evaluation of pan-PI3-kinase in

In vitro evaluation of pan-PI3-kinase inhibitor SF1126 in trastuzumab-sensitive and trastuzumab-resistant HER2-over-expressing breast cancer cells

✍ Tuba Ozbay; Donald L. Durden; Tongrui Liu; Ruth M. O’Regan; Rita Nahta 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 516 KB

Preoperative therapy with trastuzumab an

Preoperative therapy with trastuzumab and oral vinorelbine (± endocrine therapy) in patients with HER2-positive breast cancer

✍ Monica Iorfida; Vincenzo Bagnardi; Alessandra Balduzzi; Silvia Dellapasqua; Anna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 155 KB